Trust linked to DENTSPLY SIRONA (XRAY) director adds 15,000 common shares

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director-related entity buys shares. A trust associated with director Gregory T. Lucier purchased 15,000 shares of common stock in an open-market transaction at a weighted average price of $12.445 per share. Following this purchase, the trust held 65,000 shares indirectly for his benefit.

Separate indirect holdings reported, with no new transactions shown, include 24,901.284 shares held by a family partnership and 21,000 shares held by a Gregory Lucier IRA.

Insider Trade Summary

Net Buyer: 15,000 shares ($186,675)

Net Buy 3 txns

Insider LUCIER GREGORY T

Role Director

Bought 15,000 shs ($187K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	15,000	$12.445	$187K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 65,000 shares (Indirect, By a Trust)

Footnotes (1)

1. By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.43 to $12.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUCIER GREGORY T

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		P		15,000(1)	A	$12.445(2)	65,000	I	By a Trust
Common Stock								24,901.284	I	By Family Partnership
Common Stock								21,000	I	By Gregory Lucier IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.43 to $12.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did XRAY director Gregory T. Lucier report?

A trust associated with XRAY director Gregory T. Lucier bought 15,000 common shares in an open-market transaction at a weighted average price of $12.445 per share, increasing that trust’s indirect holdings to 65,000 shares.

At what price were the XRAY shares purchased in the reported transaction?

The reported weighted average purchase price was $12.445 per share, with multiple trades executed between $12.43 and $12.45. The filing notes the reporting person can provide full breakdowns of share amounts at each separate execution price upon request.

How many XRAY shares does the trust linked to Gregory Lucier hold after the purchase?

After the 15,000-share purchase, the trust linked to Gregory Lucier holds 65,000 XRAY common shares indirectly. Lucier serves as trustee and is a beneficiary, but he disclaims beneficial ownership except to the extent of his pecuniary interest in the trust.

What other indirect XRAY holdings related to Gregory Lucier are disclosed?

The filing also reports 24,901.284 XRAY shares held indirectly through a family partnership and 21,000 shares held through a Gregory Lucier IRA. These positions are shown as holdings, with no specific new buy or sell transaction amounts disclosed for them.

Does Gregory Lucier fully own the XRAY shares held by the trust?

No. The filing states the trust holds the shares, with Lucier as trustee and beneficiary, and that he disclaims beneficial ownership except for his pecuniary interest. This clarifies he does not claim full economic ownership of all trust-held XRAY shares.